MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 10-24-2023
NextGen Healthcare Retained Earnings 2011-2026 | NXGN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings NextGen Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 129 M | 119 M | 112 M | 78.7 M | 76.2 M | 58 M | 84.5 M | 99.9 M | 127 M | 126 M | 91.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 129 M | 58 M | 100 M |
Quarterly Retained Earnings NextGen Healthcare
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 139 M | 128 M | - | 145 M | - | 130 M | 130 M | 125 M | 131 M | 129 M | 129 M | 129 M | 118 M | 119 M | 123 M | 119 M | 113 M | 112 M | 108 M | 103 M | 89.8 M | 78.7 M | 89.8 M | 88.2 M | 80.2 M | 76.2 M | 71.8 M | 61.3 M | 57.3 M | 58 M | 74.3 M | 77.7 M | 80.1 M | 84.5 M | 84.4 M | 88.5 M | 94.4 M | 99.9 M | 105 M | 129 M | 129 M | 127 M | 141 M | 136 M | 131 M | 126 M | 121 M | 110 M | 99.9 M | 91.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 145 M | 57.3 M | 106 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
-606 M | $ 2.51 | -0.79 % | $ 235 M | USA |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.23 | 3.72 % | $ 860 M | USA |
 |
SCWorx Corp.
WORX
|
-35.4 M | - | - | $ 7.71 M | USA |
 |
Akerna Corp.
KERN
|
-52.5 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 24.8 | 5.17 % | $ 2.91 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 6.05 | 2.02 % | $ 104 M | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.12 | 5.66 % | $ 78.3 M | USA |
 |
HealthEquity
HQY
|
196 M | $ 81.36 | 1.81 % | $ 7.01 B | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
-629 M | $ 11.91 | 4.02 % | $ 875 M | USA |
 |
Phreesia
PHR
|
-799 M | $ 8.6 | 0.47 % | $ 514 M | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 5.24 | 0.38 % | $ 923 M | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 5.51 | -0.72 % | $ 88.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
109 M | $ 20.34 | -0.15 % | $ 618 M | USA |
 |
Omnicell
OMCL
|
383 M | $ 36.33 | 3.77 % | $ 1.67 B | USA |
 |
Progyny
PGNY
|
144 M | $ 17.17 | 1.12 % | $ 1.47 B | USA |
 |
So-Young International
SY
|
-926 M | $ 2.76 | 2.6 % | $ 219 M |  China |
 |
Veeva Systems
VEEV
|
4.36 B | $ 159.09 | 0.4 % | $ 26 B | USA |
 |
Zhongchao
ZCMD
|
-14.2 M | $ 1.99 | -1.24 % | $ 6.8 M | China |